XSTO
KONT
Market cap4mUSD
Oct 05, Last price
1.23SEK
1D
2.50%
1Q
-29.71%
Jan 2017
-68.05%
IPO
-83.15%
Name
Kontigo Care AB
Chart & performance
P/E
—
P/S
1.49
EPS
—
Div yield, %
—
Shrs. gr., 5y
8.88%
Rev. gr., 5y
7.41%
Revenues
29m
-3.66%
Net income
-2m
L
CFO
5m
+8.55%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Kontigo Care AB (publ) specializes in delivering healthcare solutions aimed at addressing addiction issues within Sweden. Their product portfolio includes Previct Alcohol, a digital medical device designed to manage alcohol dependence, and Previct Gambling, a digital application for tackling gambling addiction. Established in 2013, the firm maintains its primary operations in Uppsala, Sweden.
Key people
Ulf Kindefalt
Chief Executive Officer · since 2019
Anja Peters
Chief Financial Officer · since 2019
Fredrik Remaeus
Software Manager
Maria Winkvist
Product Manager
Agneta Bergvall
Director · since 2016
Michael Collaros
Director · since 2018
Jan Fock
Vice Chairman of the Board
Markku Hamalainen
Head of Research, Director
Ove Joanson
Chairman of the Board · since 2018
Juha Thumer
Director · since 2017
Headquarters & legal address
Bangårdsgatan 4C
Uppsala, C 753 20
SE
Uppsala, C 753 20
SE
Address
Bangardsgatan 4C
Uppsala, C 753 20
SE
Uppsala, C 753 20
SE
Previous name
Startskottet 4656 AB
Previous name
Kontigo i Uppsala AB
Valuation
Title SEK in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||